EARNINGS (LOSS) PER SHARE |
14.
EARNINGS (LOSS) PER SHARE
The
net income (loss) per common share amounts were determined as follows:
SCHEDULE OF NET INCOME (LOSS) PER COMMON SHARE
| |
May
31, 2025 | | |
May
31, 2024 | |
| |
For the Three Months Ended | |
| |
May 31, 2025 | | |
May 31, 2024 | |
Numerator: | |
| | | |
| | |
Net income (loss) available to common shareholders | |
$ | (4,594,018 | ) | |
$ | (4,194,359 | ) |
| |
| | | |
| | |
| |
| | | |
| | |
Effect of common stock equivalents | |
| | | |
| | |
Less: dividends to C preferred shareholders | |
| (12,073 | ) | |
| — | |
Net income (loss) adjusted for common stock equivalents | |
| (4,606,091 | ) | |
| (4,194,359 | ) |
| |
| | | |
| | |
Denominator: | |
| | | |
| | |
Weighted average shares – basic | |
| 15,517,671,159 | | |
| 9,882,118,105 | |
| |
| | | |
| | |
Net income (loss) per share – basic | |
$ | (0.00 | ) | |
$ | (0.00 | ) |
| |
| | | |
| | |
Denominator: | |
| | | |
| | |
Weighted average shares – diluted | |
| 15,517,671,159 | | |
| 9,882,118,105 | |
| |
| | | |
| | |
Net income (loss) per share – diluted | |
$ | (0.00 | ) | |
$ | (0.00 | ) |
The
anti-dilutive shares of common stock equivalents for the three months ended May 31, 2025 and 2024 were as follows:
SCHEDULE OF ANTI-DILUTIVE SHARES OF COMMON STOCK EQUIVALENTS
| |
May
31, 2025 | | |
May
31, 2024* | |
| |
For the Three Months Ended | |
| |
May 31, 2025 | | |
May 31, 2024* | |
Convertible Series F Preferred Shares | |
| 58,641,215,500 | | |
| 35,600,264,971 | |
Convertible Redeemable Series B & C Preferred Shares | |
| 295,826,429 | | |
| 59,933,023 | |
Stock options and warrants | |
| 226,177,522 | | |
| 486,251,667 | |
Total | |
| 59,163,219,451 | | |
| 36,146,449,661 | |
|